{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:58:04Z","timestamp":1785772684698,"version":"3.56.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100017559","name":"Recordati Rare Diseases Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK121888"],"award-info":[{"award-number":["K23DK121888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DK132121"],"award-info":[{"award-number":["R03DK132121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Glucocorticoid withdrawal syndrome (GWS) may develop in patients following successful surgery for endogenous hypercortisolism. Effective strategies to minimize GWS and improve quality of life (QoL) are currently lacking. We aimed to determine the impact of hydrocortisone vs prednisone therapy on GWS and QoL during the first 12 weeks postsurgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Single-center prospective cohort study (2019-2024) of adults with endogenous hypercortisolism who developed postoperative adrenal insufficiency and treated with either prednisone or hydrocortisone. Quality of life was assessed with Short Form-36 (SF-36) and Cushing QoL questionnaires at baseline and at 12 weeks postsurgery. GWS was assessed using weekly AddiQoL questionnaires for the first 12 weeks postsurgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 165 patients, 101 (61%) were treated with hydrocortisone and 64 (39%) with prednisone. At baseline, no group differences were found in the hypercortisolism subtype, comorbidities, or QoL assessments. At follow-up, no group differences in final total daily hydrocortisone equivalent dose were seen.<\/jats:p>\n                  <jats:p>When adjusting for the baseline QoL assessment, patients treated with prednisone demonstrated a higher degree of improvement in their QoL, particularly in the SF-36 mental component score (estimate 0.33, 95% CI, 0.04-0.63), SF-36 role-emotional limitation (estimate 0.52, 95% CI, 0.2-0.84), and SF-36 body pain (estimate 0.31, 95% CI, 0.07-0.56) subcomponents. In the multivariable analysis of age, sex, body mass index, glucocorticoid type, baseline clinical severity score, and baseline QoL assessment, prednisone therapy was an independent predictor of better SF-36 mental component at 12 weeks postsurgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Prednisone therapy was associated with better mental health QoL than hydrocortisone at 12 weeks postsurgery in patients with hypercortisolism.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf092","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:15:18Z","timestamp":1746263718000},"page":"621-630","source":"Crossref","is-referenced-by-count":9,"title":["Impact of hydrocortisone vs prednisone therapy on postsurgical recovery in patients with endogenous hypercortisolism: a prospective cohort study"],"prefix":"10.1093","volume":"192","author":[{"given":"Rashi","family":"Sandooja","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"},{"name":"Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center , Omaha, NE 68198, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-6229","authenticated-orcid":false,"given":"Jasmine","family":"Saini","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"},{"name":"Department of Internal Medicine, Yale New Haven Hospital, Yale School of Medicine , New Haven, CT 06520, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Ferreira Taveras","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Gregg-Garcia","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"},{"name":"Department of Internal Medicine, Indiana University , Indianapolis, IN 46202, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-2673","authenticated-orcid":false,"given":"Catherine D","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"},{"name":"Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin , Milwaukee, WI 53226, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Fell","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anina","family":"Peersen","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie J","family":"Van Gompel","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":false,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic , Rochester, MN 55905, United States"},{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"7","key":"2025052712233278200_lvaf092-B1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ejendo\/lvad073","article-title":"Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study","volume":"188","author":"Zhang","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2025052712233278200_lvaf092-B2","doi-asserted-by":"publisher","first-page":"bvab109","DOI":"10.1210\/jendso\/bvab109","article-title":"Patient and provider perspectives on postsurgical recovery of Cushing syndrome","volume":"5","author":"Acree","year":"2021","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025052712233278200_lvaf092-B3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11102-022-01218-y","article-title":"Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome","volume":"25","author":"He","year":"2022","journal-title":"Pituitary"},{"issue":"4","key":"2025052712233278200_lvaf092-B4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1210\/er.2001-0014","article-title":"Endocrine withdrawal syndromes","volume":"24","author":"Hochberg","year":"2003","journal-title":"Endocr Rev"},{"issue":"6","key":"2025052712233278200_lvaf092-B5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/cen.13803","article-title":"Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess","volume":"89","author":"Hurtado","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2025052712233278200_lvaf092-B6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/MED.0000000000000804","article-title":"Glucocorticoid withdrawal syndrome: what to expect and how to manage","volume":"30","author":"Theiler-Schwetz","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"2025052712233278200_lvaf092-B7","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","article-title":"European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency","volume":"190","author":"Beuschlein","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2025052712233278200_lvaf092-B8","doi-asserted-by":"publisher","first-page":"n1380","DOI":"10.1136\/bmj.n1380","article-title":"Glucocorticoid induced adrenal insufficiency","volume":"374","author":"Prete","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"2025052712233278200_lvaf092-B9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ejendo\/lvad041","article-title":"Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome","volume":"188","author":"Vogel","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025052712233278200_lvaf092-B10","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1210\/jcem.81.6.8964868","article-title":"Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency?","volume":"81","author":"Papanicolaou","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025052712233278200_lvaf092-B11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1210\/jcem.77.1.8392083","article-title":"The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome","volume":"77","author":"Gomez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025052712233278200_lvaf092-B12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/cen.14568","article-title":"Prevalence of sarcopenia after remission of hypercortisolism and its impact on HRQoL","volume":"95","author":"Martel-Duguech","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"62","key":"2025052712233278200_lvaf092-B13","doi-asserted-by":"publisher","first-page":"106113","DOI":"10.18632\/oncotarget.20597","article-title":"Comparison of hydrocortisone and prednisone in the glucocorticoid replacement therapy post-adrenalectomy of Cushing's syndrome","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2025052712233278200_lvaf092-B14","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025052712233278200_lvaf092-B15","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025052712233278200_lvaf092-B16","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025052712233278200_lvaf092-B17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2025052712233278200_lvaf092-B18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/ejendo\/lvad069","article-title":"Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study","volume":"188","author":"Li","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4 Suppl.","key":"2025052712233278200_lvaf092-B19","first-page":"AS264","article-title":"Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study","volume":"33","author":"Ware","year":"1995","journal-title":"Med Care"},{"issue":"5","key":"2025052712233278200_lvaf092-B20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025052712233278200_lvaf092-B21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function","volume":"63","author":"Meikle","year":"1977","journal-title":"Am J Med"},{"issue":"11","key":"2025052712233278200_lvaf092-B22","doi-asserted-by":"publisher","first-page":"e2031","DOI":"10.1210\/clinem\/dgae059","article-title":"A retrospective study on weaning glucocorticoids and recovery of the hypothalamic-pituitary-adrenal axis","volume":"109","author":"Arshad","year":"2024","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf092\/63049928\/lvaf092.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/5\/621\/63049928\/lvaf092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/5\/621\/63049928\/lvaf092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:23:39Z","timestamp":1748363019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/5\/621\/8124471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf092","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,30]]}}}